Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Prevention of COVID-19 Progression (ACTION)
NCT04332107Phase 3Terminated
- Start
- May 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in coronavirus disease 2019 (COVID-19). Started May 2020; status: terminated.
02
Drugs
azithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04332107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332107.